# Ireland exports to the United States: Trade Route Risk | Yugalinks

Understand reported exports from Ireland to the United States, the product routes that need a closer look, and the conditions that may affect planning.

Canonical: https://www.yugalinks.com/trade/corridor/IRL-USA/risk

## Route overview

In 2024, Ireland reported $90.5B in goods exports to the United States. The overall review level is High attention.

## How to read this page

High attention means one or more conditions on these product types deserve a closer look. It is not a prediction that trade will stop or that a loss is certain. An HS6 code is the international six-digit code used to describe and compare traded goods.

## Key numbers

| Measure | Value | What it means |
| --- | ---: | --- |
| Latest reported exports | $90.5B | 2024 route total |
| Exports needing review | 54.9% | Share of route exports |
| Highest-priority products | 10 | Need the closest review |
| Products needing review | 140 | High-attention product types |
| Export volatility | 1.2 | Higher means bigger yearly swings |
| Below highest year | 10.8% | Compared with the route's best year |

## Product types to review

| Rank | HS6 | Product | Buyer-market imports | Below product high | Review level |
| ---: | --- | --- | ---: | ---: | --- |
| 1 | 293719 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $16.4B | 0% | High attention |
| 2 | 300215 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $67.6B | 0% | Stable |
| 3 | 300214 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $15.4B | 0% | High attention |
| 4 | 300490 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $76.8B | 17.7% | Stable |
| 5 | 293359 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.3B | 0% | High attention |
| 6 | 300220 | Vaccines: for human medicine | $11.3B | 0% | High attention |
| 7 | 330210 | Odoriferous substances and mixtures: of a kind used in the food or drink industries | $4.4B | 0% | High attention |
| 8 | 901839 | Medical, surgical instruments and appliances: catheters, cannulae and the like | $10.2B | 13.1% | Stable |
| 9 | 902131 | Artificial parts of the body | $3.3B | 0% | High attention |
| 10 | 901890 | Medical, surgical or dental instruments and appliances: n.e.c. in heading no. 9018 | $19.2B | 0% | Stable |

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-29). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.